S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(0.97%) $80.00
Gas
(5.73%) $2.64
Gold
(1.44%) $2 419.80
Silver
(6.36%) $31.78
Platinum
(2.18%) $1 094.70
USD/EUR
(-0.02%) $0.920
USD/NOK
(-0.18%) $10.68
USD/GBP
(-0.27%) $0.787
USD/RUB
(0.19%) $91.05

实时更新: ProKidney Corp. [PROK]

交易所: NASDAQ Capital Market 部门: Healthcare 工业: Biotechnology
BUY
100.00%
return 5.98%
SELL
0.00%
return 5.90%
最后更新时间18 May 2024 @ 04:00

6.99% $ 4.06

购买 138235 min ago

@ $1.280

发出时间: 13 Feb 2024 @ 22:30


回报率: 216.80%


上一信号: Feb 13 - 03:52


上一信号: 出售


回报率: -3.76 %

Live Chart Being Loaded With Signals

Commentary (18 May 2024 @ 04:00):

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract...

Stats
今日成交量 546 394
平均成交量 774 563
市值 939.54M
EPS $0 ( 2024-05-09 )
下一个收益日期 ( $-0.220 ) 2024-08-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -7.11
ATR14 $0.00700 (0.17%)
Insider Trading
Date Person Action Amount type
2024-03-25 Control Empresarial De Capitales S.a. De C.v. Buy 30 000 Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)
2024-03-22 Control Empresarial De Capitales S.a. De C.v. Buy 14 000 Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)
2024-03-20 Control Empresarial De Capitales S.a. De C.v. Buy 33 000 Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)
2024-03-14 Control Empresarial De Capitales S.a. De C.v. Buy 50 000 Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)
2024-03-13 Control Empresarial De Capitales S.a. De C.v. Buy 50 000 Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)
INSIDER POWER
-30.35
Last 98 transactions
Buy: 21 980 380 | Sell: 30 162 499

音量 相关性

長: 0.28 (neutral)
短: 0.36 (neutral)
Signal:(69.74) Neutral

ProKidney Corp. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

ProKidney Corp. 相关性 - 货币/商品

The country flag 0.32
( neutral )
The country flag 0.48
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.54
( weak negative )
The country flag -0.09
( neutral )

ProKidney Corp. 财务报表

Annual 2023
营收: $0
毛利润: $-3.17M (0.00 %)
EPS: $-0.570
FY 2023
营收: $0
毛利润: $-3.17M (0.00 %)
EPS: $-0.570
FY 2022
营收: $0
毛利润: $-3.04M (0.00 %)
EPS: $-2.41
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-0.296

Financial Reports:

No articles found.

ProKidney Corp. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

ProKidney Corp.

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。